-
71.
公开(公告)号:US11081235B2
公开(公告)日:2021-08-03
申请号:US16432212
申请日:2019-06-05
Inventor: Michal A. Rahat , Nitza Lahat , Miriam Walter , Haim Bitterman
IPC: A61K39/00 , G16H50/30 , C07K16/28 , C07K14/705 , C12N15/62 , G01N33/574 , C07K14/435 , C07K7/06 , C07K7/08 , G01N33/68 , A61K38/00
Abstract: The invention provides isolated peptides from the protein EMMPRIN (CD147/Basigin) and antibodies directed against antigenic determinants within said peptides. Pharmaceutical compositions comprising said peptides and antibodies are also disclosed as well as methods of their production and use in vaccination, immunotherapy and diagnosis of proliferative, hyperpermeability, inflammatory, and angiogenesis-related diseases and disorders.
-
公开(公告)号:US20210206834A1
公开(公告)日:2021-07-08
申请号:US17154864
申请日:2021-01-21
Applicant: MOR RESEARCH APPLICATIONS LTD.
Inventor: Dov WEINBERGER , Tami LIVNAT , Yael NISGAV
IPC: C07K14/745 , A61P27/02 , A61K45/06
Abstract: Methods for treating and/or preventing choroidal neovascularization (CNV) or retinal leakage associated with CNV are disclosed, comprising the use of activated protein C (APC) and/or an APC variant. A disclosed method may be applied in the treatment or prevention of ocular diseases, disorders or conditions that are caused directly by CVN, feature development of CNV as a secondary stage or a complication thereof, and/or feature CNV as a synchronous or asynchronous sequela thereof. An exemplary disease treatable by a disclosed method is neovascular age-related macular degeneration (nAMD).
-
公开(公告)号:US10952903B2
公开(公告)日:2021-03-23
申请号:US15911895
申请日:2018-03-05
Applicant: MOR RESEARCH APPLICATIONS LTD.
Inventor: Ariel Margulis
Abstract: A method for repairing a perforation in a tympanic membrane comprising attaching a single patch to an undersurface of the tympanic membrane covering the perforation.
-
公开(公告)号:US20200261405A1
公开(公告)日:2020-08-20
申请号:US16756575
申请日:2018-10-18
Applicant: MOR RESEARCH APPLICATIONS LTD.
Inventor: Noach BEN-SHALOM , Dror ROBINSON
Abstract: The present invention provides a composition based on cannabidiol (CBD) and chitosan for use in reducing blood cholesterol, blood LDL and blood triglycerides levels.
-
公开(公告)号:US10744032B2
公开(公告)日:2020-08-18
申请号:US15775515
申请日:2016-11-10
Applicant: MOR RESEARCH APPLICATIONS LTD.
Inventor: Eliyahu Bsharim , Tova Lifshitz , Nadav Yaakov Belfair
IPC: A61F9/007
Abstract: An ophthalmic surgical instrument for fragmenting the lens nucleus of an eye, and method of use thereof. The instrument includes an elongated handle portion, a tubular head portion at the handle portion distal end, at least three prongs with cutting tips, and a holding ring. The prongs are selectively retractable into and deployable from the head portion. The holding ring selectively contracts and expands to adjust the deployment width of the prongs. The instrument is inserted toward the eye lens through a corneal incision, while the head portion is opened to deploy the prongs to slide over and grasp onto the lens nucleus at a posterior position thereof. The instrument is then withdrawn toward the eye lens anterior while the head portion is closed to retract the prongs, such that the prong cutting tips cut along the lens nucleus, so as to fragment the lens nucleus into multiple segments.
-
76.
公开(公告)号:US10557173B2
公开(公告)日:2020-02-11
申请号:US15014074
申请日:2016-02-03
Applicant: Mor Research Applications Ltd.
Inventor: Smadar Avigad , Isaac Yaniv
IPC: C12Q1/68 , C12Q1/6886
Abstract: The present invention relates to prognostic methods and kits for the assessment and monitoring of relapse-free or disease-free survival of ALL patients. The detection is based on the use of detecting nucleic acids, specific for determination of the expression of at least one of miR-151-5p and miR-451 in a test sample. The invention thereby also provides methods and kits for monitoring and early diagnosis of cancerous disorders associated with low miR-151-5p and/or miR-451 expression, specifically ALL, and appropriate associated treatments thereof.
-
公开(公告)号:US20190383815A1
公开(公告)日:2019-12-19
申请号:US16480342
申请日:2018-01-25
Inventor: Esther RABIZADEH , Izchak CHERNY , Aida INBAL
IPC: G01N33/574 , G01N33/86
Abstract: A method for diagnosing a malignant proliferative disease or disorder in a subject, and/or for following up, monitoring or prognosticating the therapy of a malignant proliferative disease or disorder in a subject is disclosed. The method is based on measurement of platelet-mediated fibrinogen-like protein 2 (FGL2) activity in a sample essentially comprising platelets obtained from the subject. In accordance with the disclosed method, platelet-mediated FGL2 activity level higher than control is indicative of the presence of a malignant proliferative disease or disorder in a subject.
-
公开(公告)号:US20190142448A1
公开(公告)日:2019-05-16
申请号:US16098474
申请日:2017-05-04
Applicant: MOR Research Applications Ltd.
Inventor: Igor Igov
IPC: A61B17/29
Abstract: The subject matter discloses a grasper, comprising a grasping element at a distal end of the grasper; wherein the grasping element is configurable to at least a narrow state having a narrow cross-section, and at least an expanded state having an expanded cross-section; wherein the grasping element configured in the narrow state is insertable through an incision or narrow orifice into a body; wherein the grasping element configured in the expanded state has an increased grasping surface; and wherein the grasping element is configurable from the narrow state to the expanded state after insertion into the body.
-
公开(公告)号:US10206900B2
公开(公告)日:2019-02-19
申请号:US15083370
申请日:2016-03-29
Applicant: MOR RESEARCH APPLICATIONS LTD.
Inventor: Ayala Pollack , Zeev Dvashi
IPC: A61K31/335 , C07K16/40
Abstract: Disclosed herein are methods for treatment for fibrosis, ocular pathologies associated with fibrosis, including proliferative vitreoretinopathy (PVR) by inhibiting the activity of activated transforming growth factor β activated kinase 1 (TAK1), or activation thereof. Pharmaceutical compositions for use in the described treatments are also provided.
-
公开(公告)号:US20180235644A1
公开(公告)日:2018-08-23
申请号:US15962285
申请日:2018-04-25
Applicant: MOR RESEARCH APPLICATIONS LTD.
Inventor: Ronen JAFFE , Eytan JAFFE
IPC: A61B17/221
CPC classification number: A61B17/221 , A61B17/22032 , A61B2017/22034 , A61B2017/22054 , A61B2017/22067 , A61B2017/22079 , A61B2017/2215 , A61B2217/005 , A61M2025/1059
Abstract: A catheter for removable insertion into a body vasculature has at least one inflatable member. The catheter has at least in part an expandable body that forms an internal axially extending lumen in at least the expanded state of the body. The inflatable member is adjacent a distal axial end of the body and is configured to at least partially obstruct the lumen.
-
-
-
-
-
-
-
-
-